These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 355821)

  • 1. Increased survival in childhood acute nonlymphocytic leukemia after treatment with prednisone, cytosine arabinoside, 6-thioguanine, cyclophosphamide, and oncovin (PATCO) combination chemotherapy.
    Chard RL; Finklestein JZ; Sonley MJ; Nesbit M; McCreadie S; Weiner J; Sather H; Hammond GD
    Med Pediatr Oncol; 1978; 4(3):263-73. PubMed ID: 355821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daunomycin, cytosine arabinoside and 6-thioguanine (DAT) vs vincristine, cytosine arabinoside and 6-thioguanine (VAT) in the induction treatment of acute nonlymphocyte leukemia: a randomized collaborative study.
    Mandelli F; De Lipsis E; Grignani F; Martelli M; Liso V; Amadori S
    Med Pediatr Oncol; 1978; 4(3):231-40. PubMed ID: 277749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose combination chemotherapy for acute nonlymphoblastic leukemia in adults.
    Glucksberg H; Cheever MA; Farewell VT; Fefer A; Sale GE; Thomas ED
    Cancer; 1981 Sep; 48(5):1073-81. PubMed ID: 7023650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive five-drug combination chemotherapy for adult acute non-lymphocytic leukemia.
    Peterson BA; Bloomfield CD; Bosl GJ; Gibbs G; Malloy M
    Cancer; 1980 Aug; 46(4):663-8. PubMed ID: 7397631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of intermittent alternating drug program reinduction therapy on the frequency and duration of response in adult acute leukemia.
    McCredie KB; Freireich EJ; Bodey GP; Burgess MA; Whitecar JP; Smith TL
    Med Pediatr Oncol; 1976; 2(3):309-18. PubMed ID: 979915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved remission induction rate with D-ZAPO but unimproved remission duration with addition of immunotherapy to chemotherapy in previously untreated children with ANLL.
    Baehner RL; Bernstein ID; Sather H; Higgins G; McCreadie S; Chard RL; Hammond D
    Med Pediatr Oncol; 1979; 7(2):127-39. PubMed ID: 291771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide, cytosine arabinoside and methotrexate versus cytosine arabinoside and thioguanine for acute non-lymphocytic leukemia in adults.
    Skeel RT; Costello W; Bennett JM; Oken MM; Tobin MS; Bertino JR; Marsh JC; Carbone PP
    Cancer; 1980 Jan; 45(2):224-31. PubMed ID: 6985830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vincristine (NSC-67574), cytosine arabinoside (NSC-63878), 6 thioguanine (NSC-752) and daunorubicin (NSC-82151) (VAT-D): a pilot study of combination chemotherapy for remission induction in acute myeloid leukemia in adults.
    Sartiano GP; Pfrimmer WJ; Turner AR
    Med Pediatr Oncol; 1978; 4(3):205-12. PubMed ID: 277748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission maintenance for acute nonlymphocytic leukemia: cytosine arabinoside plus 6-thioguanine versus a sequence of drug regimens.
    Presant CA; Berger NA; Klahr C; Phillips GL
    Cancer; 1980 Jul; 46(1):22-8. PubMed ID: 6930320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved survival in young children with acute granulocytic leukemia treated with combination therapy using cyclophosphamide, oncovin, cytosine arabinoside, and prednisone.
    Madanat FF; Sullivan MP
    Cancer; 1979 Sep; 44(3):819-23. PubMed ID: 289434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: a report from Children's Cancer Study Group.
    Movassaghi N; Higgins G; Pyesmany A; Baehner R; Chard R; Sather H; Hammond D
    Med Pediatr Oncol; 1984; 12(5):352-6. PubMed ID: 6208468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
    Maluf PT; Odone Filho V; Cristofani LM; Britto JL; Almeida MT; Pontes E; Maksoud JG; Manissadjian A
    J Clin Oncol; 1994 Sep; 12(9):1963-8. PubMed ID: 8083717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy in childhood acute nonlymphocytic leukemia (ANLL). Evolution of current concepts of chemotherapy.
    Steuber CP
    Am J Pediatr Hematol Oncol; 1981; 3(4):379-88. PubMed ID: 6174052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of aggressive chemotherapy for acute nonlymphoblastic leukemia in adults.
    Armitage JO; Burns CP; Dick FR; Aunan SB; Slymen DJ
    Cancer Treat Rep; 1982 Nov; 66(11):1917-24. PubMed ID: 7139637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of therapy-associated acute nonlymphocytic leukemia to intensive induction chemotherapy.
    Duane SF; Peterson BA; Bloomfield CD; Michels SD; Hurd DD
    Med Pediatr Oncol; 1985; 13(4):207-13. PubMed ID: 4010622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult acute leukaemia.
    Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
    Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reinduction chemotherapy for acute nonlymphocytic leukemia.
    Letendre L; Kiely JM; Hoagland HC
    Mayo Clin Proc; 1984 Sep; 59(9):618-21. PubMed ID: 6381915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
    Lönnqvist B; Andersson B; Björkholm M; Engstedt L; Gahrton G; Hast R; Holm G; Killander A; Lantz B; Lockner D; Mellstedt H; Palmblad J; Paul C; Peterson C; Simonsson B; Stalfelt AM; Udén AM; Wadman B; Oberg G
    Cancer Chemother Pharmacol; 1982; 9(2):89-92. PubMed ID: 7172410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokinetically based induction chemotherapy and splenectomy for childhood acute nonlymphocytic leukemia.
    Dahl GV; Kalwinsky DK; Murphy S; Look AT; Amadori S; Kumar M; Novak R; George SL; Mason C; Mauer AM; Simone JV
    Blood; 1982 Oct; 60(4):856-63. PubMed ID: 6896834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.